Europe PMC
open access
Advances in pharmacological interventions for hepatic fibrosis: from pathogenic mechanisms to novel therapeutic targets
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- New approach methodologies to model liver fibrosis in metabolic dysfunction-associated steatohepatitis.#145980
- Safety, Tolerability, Pharmacokinetics and Efficacy of LMB763 in Patients With NASH#1032275
- Sitagliptin Versus Placebo in the Treatment of Non-alcoholic Fatty Liver Disease#900547
- A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis#880626
- Bicalutamide Therapy in Young Women With NAFLD and PCOS#906466
Record · ID 4703
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive